Article Cited by others

ORIGINAL ARTICLE

Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers

Almubarak Hussain, Jones Antonia, Chaisuparat Risa, Zhang Ming, Meiller Timothy F, Scheper Mark A

Year : 2011| Volume: 10| Issue : 1 | Page no: 2-2

   This article has been cited by
 
1 Lantana camara Induces Apoptosis by Bcl-2 Family and Caspases Activation
Eun Byeol Han,Bo Yoon Chang,Young Suk Jung,Sung Yeon Kim
Pathology & Oncology Research. 2014;
[Pubmed]  [Google Scholar] [DOI]
2 Zoledronic acid induces apoptosis and autophagy in cervical cancer cells
I-Te Wang,Shou-Chu Chou,Ying-Chin Lin
Tumor Biology. 2014;
[Pubmed]  [Google Scholar] [DOI]
3 Crystallization and preliminary neutron diffraction experiment of human farnesyl pyrophosphate synthase complexed with risedronate
Takeshi Yokoyama,Andreas Ostermann,Mineyuki Mizuguchi,Nobuo Niimura,Tobias E. Schrader,Ichiro Tanaka
Acta Crystallographica Section F Structural Biology Communications. 2014; 70(4): 470
[Pubmed]  [Google Scholar] [DOI]
4 The Anti-Tumour Effects of Zoledronic Acid
Jamal Zekri,Maged Mansour,Syed Mustafa Karim
Journal of Bone Oncology. 2014;
[Pubmed]  [Google Scholar] [DOI]
5 Zoledronic acid reverses the epithelial-mesenchymal transition and inhibits self-renewal of breast cancer cells through inactivation of NF-κB
Schech, A.J. and Kazi, A.A. and Gilani, R.A. and Brodie, A.H.
Molecular Cancer Therapeutics. 2013; 12(7): 1356-1366
[Pubmed]  [Google Scholar]
6 Hyaluronan synthesis inhibitor supplements the inhibitory effects of zoledronic acid on bone metastasis of lung cancer
Futamura, N. and Urakawa, H. and Arai, E. and Kozawa, E. and Ishiguro, N. and Nishida, Y.
Clinical and Experimental Metastasis. 2013; 30(5): 595-606
[Pubmed]  [Google Scholar]
7 Codelivery of zoledronic acid and double-stranded RNA from core-shell nanoparticles
Chen, L. and Ding, Y. and Wang, Y. and Liu, X. and Babu, R.J. and Ravis, W.R. and Yan, W.
International Journal of Nanomedicine. 2013; 8: 137-145
[Pubmed]  [Google Scholar]
8 Hyaluronan synthesis inhibitor supplements the inhibitory effects of zoledronic acid on bone metastasis of lung cancer
Naohisa Futamura,Hiroshi Urakawa,Eisuke Arai,Eiji Kozawa,Naoki Ishiguro,Yoshihiro Nishida
Clinical & Experimental Metastasis. 2013; 30(5): 595
[Pubmed]  [Google Scholar] [DOI]
9 Zoledronic acid influences growth, migration and invasive activity of prostate cancer cells in vitro
J Mani,S Vallo,K Barth,J Makarevic,E Juengel,G Bartsch,C Wiesner,A Haferkamp,R A Blaheta
Prostate Cancer and Prostatic Diseases. 2012; 15(3): 250
[Pubmed]  [Google Scholar] [DOI]
10 Zoledronic acid inhibits aromatase activity and phosphorylation: Potential mechanism for additive zoledronic acid and letrozole drug interaction
Amanda J. Schech,Brandon E. Nemieboka,Angela H. Brodie
The Journal of Steroid Biochemistry and Molecular Biology. 2012; 132(3-5): 195
[Pubmed]  [Google Scholar] [DOI]
11 Antitumor activity of zoledronic acid in primary breast cancer cells determined by the ATP tumor chemosensitivity assay
Tanja Fehm,Manfred Zwirner,Diethelm Wallwiener,Harald Seeger,Hans Neubauer
BMC Cancer. 2012; 12(1): 308
[Pubmed]  [Google Scholar] [DOI]
12 Involvement of the mevalonate pathway in the antiproliferative effect of zoledronate on ACHN renal cell carcinoma cells
Fujita, M., Tohi, M., Sawada, K., Yamamoto, Y., Nakamura, T., Yagami, T., Yamamori, M., Okamura, N.
Oncology Reports. 2012; 27(5): 1371-1375
[Pubmed]  [Google Scholar]
13 Bisphosphonates: Prevention of bone metastases in breast cancer
Gnant, M., Dubsky, P., Hadji, P.
Recent Results in Cancer Research. 2012; 192: 65-91
[Pubmed]  [Google Scholar]
14 Zoledronic acid inhibits aromatase activity and phosphorylation: Potential mechanism for additive zoledronic acid and letrozole drug interaction
Schech, A.J. and Nemieboka, B.E. and Brodie, A.H.
Journal of Steroid Biochemistry and Molecular Biology. 2012; 132(3-5): 195-202
[Pubmed]  [Google Scholar]
15 Stathmin is involved in the cooperative effect of Zoledronic acid and gefitinib on bone homing breast cancer cells in vitro
Oda, M. and Iwaya, K. and Kuchi, R. and Kobayashi, T. and Yoneda, T. and Nishikawa, K. and Matsubara, O. and Kohno, N.
Journal of Bone Oncology. 2012; 1(2): 40-46
[Pubmed]  [Google Scholar]
16 Zoledronic acid influences growth, migration and invasive activity of prostate cancer cells in vitro
Mani, J. and Vallo, S. and Barth, K. and Makarević, J. and Juengel, E. and Bartsch, G. and Wiesner, C. and Haferkamp, A. and Blaheta, R.A.
Prostate Cancer and Prostatic Diseases. 2012; 15(3): 250-255
[Pubmed]  [Google Scholar]
17 Antitumor activity of zoledronic acid in primary breast cancer cells determined by the ATP tumor chemosensitivity assay
Fehm, T. and Zwirner, M. and Wallwiener, D. and Seeger, H. and Neubauer, H.
BMC Cancer. 2012; 12(308)
[Pubmed]  [Google Scholar]
18 Activation of BKca channels in zoledronic acid-induced apoptosis of MDA-MB-231 breast cancer cells
Ma, Y.-G. and Liu, W.-C. and Dong, S. and Du, C. and Wang, X.-J. and Li, J.-S. and Xie, X.-P. and Wu, L. and Ma, D.-C. and Yu, Z.-B. and Xie, M.-J.
PLoS ONE. 2012; 7(5)
[Pubmed]  [Google Scholar]
19 Study of sequence-dependent in vitro effects of zoledronic acid and paclitaxel upon human nasopharyngeal carcinoma cell line HNE1
Huang, W.-L. and Li, X.-Y. and Wang, H.-B. and Lin, W. and Lin, W.-Z. and Lin, S.-L. and Lin, Y.-C.
National Medical Journal of China. 2012; 92(16): 1133-1137
[Pubmed]  [Google Scholar]
20 Molecular pathways associated with mortality in papillary thyroid cancer
Nilubol, N., Sukchotrat, C., Zhang, L., He, M., Kebebew, E.
Surgery. 2011; 150(6): 1023-1031
[Pubmed]  [Google Scholar]
21 Hypercalcemia of malignancy: Patomechanism, symptoms and treatment
# Szyszka-Barth, K., Spychalski, Ł., Hałas, J., Bryl, M., Ramlau, R.
Onkologia Polska. 2011; 14(2): 103-106
[Pubmed]  [Google Scholar]
22 Antitumor effects of bisphosphonates: From the laboratory to the clinic
Berenson, J.R.
Current Opinion in Supportive and Palliative Care. 2011; 5(3): 233-240
[Pubmed]  [Google Scholar]
23 Antitumor effects of bisphosphonates
James R. Berenson
Current Opinion in Supportive and Palliative Care. 2011; 5(3): 233
[Pubmed]  [Google Scholar] [DOI]
24 Molecular pathways associated with mortality in papillary thyroid cancer
Naris Nilubol,Chotiya Sukchotrat,Lisa Zhang,Mei He,Electron Kebebew
Surgery. 2011; 150(6): 1023
[Pubmed]  [Google Scholar] [DOI]
25 Molecular markers that can be utilized in diet and dietary supplement research
Moyad, M.A., Wojno, K.J.
Urologic Clinics of North America. 2011; 38(3): 321-324
[Pubmed]  [Google Scholar]

 

Read this article